SAB Biotherapeutics (SABS) Shares Outstanding: 2020-2025
Historic Shares Outstanding for SAB Biotherapeutics (SABS) over the last 5 years, with Sep 2025 value amounting to $47.5 million.
- SAB Biotherapeutics' Shares Outstanding rose 412.16% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.5 million, marking a year-over-year increase of 412.16%. This contributed to the annual value of $9.3 million for FY2024, which is 0.68% up from last year.
- Per SAB Biotherapeutics' latest filing, its Shares Outstanding stood at $47.5 million for Q3 2025, which was up 408.74% from $9.3 million recorded in Q2 2025.
- SAB Biotherapeutics' Shares Outstanding's 5-year high stood at $47.5 million during Q3 2025, with a 5-year trough of $4.3 million in Q4 2021.
- Over the past 3 years, SAB Biotherapeutics' median Shares Outstanding value was $9.3 million (recorded in 2024), while the average stood at $11.7 million.
- In the last 5 years, SAB Biotherapeutics' Shares Outstanding tumbled by 88.29% in 2023 and then skyrocketed by 412.16% in 2025.
- SAB Biotherapeutics' Shares Outstanding (Quarterly) stood at $4.3 million in 2021, then climbed by 17.14% to $5.1 million in 2022, then surged by 82.18% to $9.3 million in 2023, then climbed by 0.68% to $9.3 million in 2024, then skyrocketed by 412.16% to $47.5 million in 2025.
- Its Shares Outstanding stands at $47.5 million for Q3 2025, versus $9.3 million for Q2 2025 and $9.3 million for Q1 2025.